2
Clinical Trials associated with Measles, mumps and rubella combined vaccine, live attenuated (Beijing Institute of Biological Products)麻腮风联合减毒活疫苗上市后在大规模人群中接种的安全性监测
[Translation] Safety monitoring of measles, mumps and rubella combined live attenuated vaccine in large-scale population after its launch
评价 MMR 上市后大规模使用的安全性;累积安全性观察数据
[Translation] Evaluate the safety of large-scale use of MMR after its launch; accumulate safety observation data
评价 麻腮风联合减毒活疫苗接种后安全性、免疫原性和批间一致性的随机、双盲、对照Ⅳ期
临床试验
[Translation] A randomized, double-blind, controlled phase IV clinical trial to evaluate the safety, immunogenicity and batch consistency of measles, mumps and rubella combined live attenuated vaccine
评价 MMR 在 8 月龄人群中接种后的批次间一致性。 以旧工艺 MMR 为对照,评价新工艺 MMR 在 8 月龄人群中接种后的免疫原性和安全性
[Translation] To evaluate the batch-to-batch consistency of MMR in 8-month-olds. To evaluate the immunogenicity and safety of MMR in 8-month-olds using the old process MMR as a control.
100 Clinical Results associated with Measles, mumps and rubella combined vaccine, live attenuated (Beijing Institute of Biological Products)
100 Translational Medicine associated with Measles, mumps and rubella combined vaccine, live attenuated (Beijing Institute of Biological Products)
100 Patents (Medical) associated with Measles, mumps and rubella combined vaccine, live attenuated (Beijing Institute of Biological Products)
100 Deals associated with Measles, mumps and rubella combined vaccine, live attenuated (Beijing Institute of Biological Products)